Influence of Pharmaceutical Sales Reps in keeping patented Brands in Doctors’ Minds

Why do doctors prescribe the most costly drugs?

Why do doctors prescribe the most costly drugs?
Did our governments leave the education of our doctors to the pharmaceutical industry?

Selling pharmaceuticals is an extremely competitive business and companies know that they need to put their best face forward. That face is usually a smiling drug representative whose job it is to teach your physician about the newest medicines being produced today.
In Canada the drug industry spends roughly $3 billion per year marketing its products, two-thirds of which goes towards the salaries of the sales reps who visit our physicians regularly, and the drug samples they use to enhance their one-on-one learning sessions
. “

Read Why do doctors prescribe the most costly drugs?
by Alan Cassels, Feb 28, 2012.

Big Pharma and Consumer Manipulations… how the Pharmaceutical Industry turns Profits

Six ways Big Pharma manipulates consumers

Six ways Big Pharma manipulates consumers
Pharma is looking at the elderly as a new market for ADHD drugs

Here are six new Pharma marketing initiatives that are guaranteed to keep investor expectations high along with our insurance premiums. The secret? Recycling old and discredited drugs and marketing diseases to sell the few new ones. ‘

  1. Repurposing Ritalin
  2. Male Hormone Replacement
  3. Calling Alcoholics and Addicts Mentally Ill and In Need of Vaccines
  4. Pathologizing Insomnia
  5. ”Selling” Chronic Immune Disorders
  6. Recycling Neurontin

Read 6 ways Big Pharma manipulates consumers
by Martha Rosenberg, Apr 28, 2013

Adult Attention Deficit Hyperactivity Disorder emerging Market… and Big Pharma Strategies

Big Pharma’s newest invention: adult ADHD

Big Pharma’s newest invention: Adult ADHD
Who belongs to this untapped market? You do, of course

There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) — that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market. In fact, adult ADHD, with symptoms similar to pediatric ADHD such as impulsivity, distractibility and difficulty paying attention, following instructions and meeting deadlines, is the next big thing “.

Read Big Pharma’s newest invention: Adult ADHD
by Martha Rosenberg, Oct 1, 2012

The Association of the British Pharmaceutical Industry revealing how much they paid UK Doctors

Drug companies pay doctors £40m for travel and expenses

Drug companies pay doctors £40m for travel and expensesDrug companies are paying an estimated £40m a year to British doctors in service fees, flights, hotel and other travel expenses, according to the trade body that represents pharmaceutical companies.

Doctors have always denied that taking drug company money influences their judgement in any way about a medicine, but suspicions have lingered.

Read Drug companies pay doctors £40m for travel and expenses
by Sarah Boseley, The Guardian, april 2013.

Pay-to-delay Deals keep Consumer Prices artificially high to protect Drug Patent-Holders’ Profits

Pay-to-delay deals costly for the general public

How ‘Pay for Delay’ Keeps Us Paying More for Prescription Drugs” … When a company’s patent on a brand-name drug expires, other companies are free to make generic versions of the same drug… Often times, there are legal disputes between brand-name drug manufacturers and generic-drug companies. It’s increasingly common for this litigation to end with out-of-court settlements in which patentholders pay potential competitors to delay the introduction of generics.
That’s pay-to-delay
… ”

Read PD Editorial: Pay-to-delay deals costly for consumers.

Read How ‘Pay for Delay’ Keeps Us Paying More for Prescription Drugs.

Will the US Sunshine Law help track Ties between Doctors and Drug Companies in America?

More transparency on doctors’ lucrative industry ties?

New efforts to reveal the ties between doctors and drug firmsThis month American regulators released rules to implement a so-called Sunshine law designed to improve transparency. France passed a similar law in 2011. Firms in Britain are planning voluntary disclosures. By 2015 more than 70% of drug sales will be in countries with such measures, according to Deloitte, a consultancy. ”

Read New efforts to reveal the ties between doctors and drug firmsLet the sunshine in, Mar 2nd 2013.

Big Pharma Drug Dealer$

Always marketing your next Illne$$

487765_10151006466398718_1005545705_n

Being sick has never been easier thanks to Big Pharma

What about DES, the FDA and Eli Lilly?
It is Time for Actions: did you SIGN THE PETITION ?

On Flickr®

Feds to publicize Big Pharma Drug and Device payments to Doctors next Year

Feds to Publicize Drug and Device Company Payments to Doctors Next Year

gt_pills_300x200_130201_1 (1)After years of anticipation, all of the nation’s drug and medical device makers must soon begin publicly reporting payments they make to U.S. physicians, according to final regulations announced this month by the federal government. ”

Read Feds to Publicize Drug and Device Company Payments to Doctors Next Year by Charles Ornstein and Tracy Weber

Experimental Pain Drugs linked with Joint Failure and Bone Deterioration

Drugmakers once touted nerve growth factor inhibitors as a potential breakthrough

Experimental Pain Drugs linked with Joint Failure and Bone DeteriorationThe power of big pharma and big money!
Drug makers often abandon research on experimental drugs that appear to have safety issues but with more than 50 million U.S. adults diagnosed with arthritis the potential multibillion dollar market opportunity may be too big to ignore …
Here we go again !!!

Read Experimental Pain Drugs linked with Joint Failure and Bone Deterioration